# Naomi Akita, MD – FDA Inspection, Oct 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/naomi-akita-md/4f47f0b4-a421-46fa-85a9-266eeb43ccdc
Source feed: FDA_Inspections

> FDA inspection 1068713 of Naomi Akita, MD, October 11, 2018. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1068713
- Company Name: Naomi Akita, MD
- Inspection Date: 2018-10-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sereen-g-morgan-murray/1900ad73-5999-471e-8f74-63627bd1aa2a)

Company: https://www.keypedia.com/companies/naomi-akita-md/075092cd-09d4-4d9b-afee-859e88a8cc12

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
